BEXIMCO PHARMS USA FDA Approval ANDA 075842

ANDA 075842

BEXIMCO PHARMS USA

FDA Drug Application

Application #075842

Documents

Letter2001-04-12

Application Sponsors

ANDA 075842BEXIMCO PHARMS USA

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL600MG0OXAPROZINOXAPROZIN

FDA Submissions

ORIG1AP2001-04-12

CDER Filings

BEXIMCO PHARMS USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75842
            [companyName] => BEXIMCO PHARMS USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"OXAPROZIN","activeIngredients":"OXAPROZIN","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"OXAPROZIN","submission":"OXAPROZIN","actionType":"600MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.